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Abnormal excessive uterine bleeding forms a large proportion of gynaecological complaints. Of postpubertal girls who experi-
ence excessive menstrual loss, about one quarter will never regain a normal cycle and flow. As she grows older many other 
factors may arise causing menstrual abnormalities.
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Introduction
Excessive menstrual bleeding (menor-
rhagia) and acyclical bleeding (metror-
rhagia), or combinations thereof, are 
the most commonly encountered forms 
of excessive menstruation. To exactly 
quantify menstrual blood loss is a dif-
ficult undertaking and is not commonly 
used in clinical practice to verify the 
complaint of excessive blood loss. For 
this reason the patient’s history is of 
extreme importance and details of the 
bleeding, type, appearance, duration, 
cyclicity and associated symptoms 
such as pain must be noted.
The current, popular term for exces-
sive menstruation is Heavy Menstrual 
Bleeding (HMB) as it is used in the UK 
NICE Guidelines. This term still has to 
gain international acceptance.
Phases of menstrual life
To understand the pathophysiology and 
clinical approach to excessive men-
struation, menstrual life can be divided 
into three phases:
1.  Adolescence (puberty until about 20 
years)
2. Reproductive years (20 - 45 years)
3.  Perimenopause (45 years to estab-
lished menopause)
Organic and dysfunctional bleeding
When excessive menstruation is caused 
by disorders of the genital tract or other 
detectable abnormalities in the body, the 
cause is described as organic. Contrary 
to this, when all findings are normal, the 
cause is described as dysfunctional.
The common organic causes are 
listed in Table I.













Uterine tubes Pelvic inflammationEctopic pregnancy
Ovary Oestrogen producing ovarian tumoursOvarian cysts
Other genital disorders
Endometriosis
Vulval tumours or lacerations
Vaginal tumours or lacerations






Breakthrough bleeding on oral contraceptives
Endocrine Hypo- or hyperthyroidismHyperprolactinaemia
Medication Anticoagulants
Haematological disease Bleeding or clotting disorders
Adjacent organs Bleeding from rectum or bladder
Table I: Organic causes of abnormal excessive menstruation
Women with acute severe blood loss 
must be resuscitated. A diagnosis 
should be made on the basis of history, 
clinical examination and special testing 
including a pregnancy test, a hemato-
crit, abdominal and pelvic ultrasound 
and, if needed, a biopsy of a present le-
sion .
Women with chronic excessive men-
struation will mostly be seen during a 
regular consultation. The history is of 
critical importance as decisions will of-
related to ovulation (15% of cases) or 
anovulation (85% of cases) is of limited 
practical importance. The only patients 
in whom this should be determined, are 
those with concurrent infertility.
Clinical approach
In all cases where the main complaint is 
that of excessive menstrual bleeding, an 
immediate differentiation must be made 
between acute severe blood loss and 
chronic excessive menstruation.
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ten have to be based on this alone. The 
characteristics of the bleeding must be 
noted in detail. The obstetric, medical 
and surgical history as well as use of 
medication, are of great importance. A 
thorough general and gynaecological 
examination should be performed. Spe-
cial investigations should include a 
pregnancy test, hematocrit and abdomi-
nal and pelvic ultrasound. The objective 
of the assessment is to exclude organic 
pathology where possible. If such pa-
thology is detected, then the patient will 
be regarded as having organic exces-
sive bleeding and treatment must be for 
that specific pathology. If no pathology 
can be detected, the patient is regarded 
as suffering from dysfunctional exces-
sive menstruation and a set of standard 
management rules can be implemented. 
In such patients additional blood tests 
can be ordered for thyroid function and 
prolactin levels.
Standard management rules for dys-
functional excessive menstruation
The first objective is to stop the bleed-
ing and then to ensure maintenance of 
cycle control.
To stop acute bleeding in a chron-
ic excessive bleeding situation, a high 
dose oestrogen and progestogen con-
taining oral contraceptive can be used 
(one month’s supply of active tablets; 
one to four tablets per day), or tranexam-
ic acid, in oral and parenteral forms.
The best available evidence suggests 
that the following steps be taken to man-
age chronic dysfunctional excessive 
menstruation (NICE guidelines):
1.  Insertion of the levonorgestrel-releas-
ing intrauterine system (in patients 
other than adolescents) as the first 
option. 
2.  Alternatives are: the use of tranexamic 
acid, non-steroidal anti-inflammatory 
drugs or combined oral contracep-
tives; if unsuccessful the use of oral 
norethisterone or depot injectable 
progestogens can be considered.
Surgical management of dysfunctional 
bleeding can be considered in patients 
with completed families where medical 
management has failed to solve the 
problem. This includes the less invasive 
procedure of endometrial ablation or a 
hysterectomy, depending on patient 
preference.
Current considerations of manage-
ment options for common organic 
disorders
The most common organic disorder is 
the uterine myoma. Non-hysterectomy 
treatment options include GnRH (go-
nadotrophin-releasing hormone) ago-
nist management to shrink the myoma, 
a myomectomy through laparotomy or 
laparoscopy, or embolisation of the uter-
ine arteries supplying the myoma. In the 
young patient wishing to retain fertility, 
GnRH agonist pre-treatment followed 
by myomectomy is often preferred. 
For patients with completed families, 
myomectomy can still be considered 
and hysterectomy now also becomes a 
treatment option.
Approach to the patient in the 
different phases of menstrual life
Adolescence
The basic problem in this age group 
is immaturity of the hypothalamic-pitu-
itary-ovarian axis resulting in prolonged 
production of oestrogens, but irregular 
ovulation. Resulting anovulatory oes-
trogen withdrawal bleeding can occur 
and can be quite severe. In a minor-
ity of patients (less than 20%) there 
may be an underlying haematological 
disorder. The approach is to the his-
tory as described, followed by a clinical 
examination and special tests. It should 
be noted that a vaginal examination or 
transvaginal ultrasound examination 
should not be performed in a virgo in-
tacta patient. Special tests will include 
a pregnancy test, full blood count and 
platelets, clotting profile, and, if abnor-
mal, tests for bleeding disorders such 
as von Willebrand’s disease. In all cases 
management will initially be medical 
with oral contraceptives and tranexamic 
acid high on the list. The patient should 
use oral contraception for periods of six 
months after which treatment can be 
interrupted to determine whether the 
cycle has improved. Medical or haema-
tological abnormalities which may occur 
should be addressed specifically.
Reproductive years
Both organic and dysfunctional exces-
sive bleeding occur during this phase. 
The assessment for organic lesions 
should be careful and thorough. Once 
dysfunctional excessive menstruation 
is diagnosed, the standard medical 
management rules will apply. In this 
menstrual life phase surgical treatment 
is also a consideration.
Perimenopause 
During this phase the majority of pa-
tients will experience anovulatory ex-
cessive bleeding due to ovarian oocyte 
depletion. However, since the more seri-
ous forms of organic pathology occur 
more commonly in this age group than 
in younger patients, great care should 
be taken to exclude such disorders. 
This will include performing endometrial 
sampling and endo- and ectocervical 
cytology. Once organic disorders have 
been excluded, the medical manage-
ment guidelines can be employed as 
set out in the NICE guidelines.  
See CPD Questionnaire, page 42
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